SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...

In the manufacture of solid dosage forms, the rate at which the active pharmaceutical ingredient (API) is dissolved into solvents simulating the digestive tract fluids is determined with dissolution ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Dissolution Testing in Pharma - From Development to Regulatory Approval" training has been added to ResearchAndMarkets.com's offering. Dissolution ...

A fully automated dissolution lab is an integrated, end to end architecture that enables reproducible testing, continuous ...

Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, analysts must understand ...

System addresses the pharmaceutical industry’s need for compliant, semi-automated testing of nanoparticle drug formulations. SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) ...

Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry, as well as an experienced provider of validation and qualification services, ...

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining ...

The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...

Suggested Citation: "5 Waste Form Testing." National Research Council. 2011. Waste Forms Technology and Performance: Final Report. Washington, DC: The National Academies Press. doi: 10.17226/13100. A ...